Suchergebnisse - "Pesce, Emanuela"

PubPharm (69)

1

Beyond Kaftrio : mechanistic insights to maximize N1303K-CFTR rescue

enthalten in: bioRxiv.org | 2024

von Pranke, I. | Capurro, V. | Chevalier, B. | +61

2

Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del-CFTR

enthalten in: ChemMedChem | 2024

von Spallarossa, A. | Pedemonte, N. | Pesce, E. | +6

3

Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del‐CFTR

enthalten in: ChemMedChem | 2024

von Spallarossa, A. | Pedemonte, N. | Pesce, E. | +6

4

Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis : Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5

enthalten in: Journal of medicinal chemistry | 2023

von Brusa, I. | Sondo, E. | Pesce, E. | +13

5

Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2023

von Tomati, V. | Costa, S. | Capurro, V. | +13

6

Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators

enthalten in: International journal of molecular sciences | 2023

von Terlizzi, V. | Pesce, E. | Capurro, V. | +9

7

Changing the Microstructural and Chemical Properties of Graphene Oxide Through a Chemical Route

enthalten in: Applied spectroscopy | 2022

von Protopapa, M. | Burresi, E. | Plamisano, M. | +6

8

Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing

enthalten in: International journal of molecular sciences | 2022

von Fossa, P. | Uggeri, M. | Orro, A. | +10

9

Towards Innovative Antibacterial Correctors for Cystic Fibrosis Targeting the Lung Microbiome with a Multifunctional Effect

enthalten in: ChemMedChem | 2022

von Martina, M. | Sannio, F. | Crespan, E. | +9

10

The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients : The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs

enthalten in: International journal of molecular sciences | 2022

von Sondo, E. | Cresta, F. | Pastorino, C. | +13

1
2
3
4
5
6
7
Nächster »
[7]